|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-27.92% | -62.93% |
| Apr. 11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
| Feb. 20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
Myriad Group AG announced Stephen Dunford has been appointed as Chief Executive Officer of Myriad Group with immediate effect. Stephen Dunford has a long track record of building value within telecoms software and services businesses. Most recently he was CEO at Spectrum Motion Media.
He has previously held CEO, Chairman and Board Member roles for X-Cell Communications, Elata Ltd, Celltick Technologies, WDS Global and mobile messaging specialist Alamein.
| 1st Jan change | Capi. | |
|---|---|---|
| -62.93% | 0 | |
| +9.65% | 3,051B | |
| +6.79% | 83.97B | |
| +4.74% | 76.9B | |
| -13.91% | 54B | |
| +23.12% | 48.01B | |
| -24.39% | 46.47B | |
| +23.22% | 42.04B | |
| +62.94% | 38.34B | |
| -33.46% | 24.97B |
MYRIAD GROUP AG 